These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 9604123

  • 21. Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers.
    Lee J, Lee H, Jang K, Lim KS, Shin D, Yu KS.
    Drug Des Devel Ther; 2014; 8():1781-8. PubMed ID: 25336921
    [Abstract] [Full Text] [Related]

  • 22. Bioequivalence study of a valsartan tablet and a capsule formulation after single dosing in healthy volunteers using a replicated crossover design.
    Séchaud R, Graf P, Bigler H, Gruendl E, Letzkus M, Merz M.
    Int J Clin Pharmacol Ther; 2002 Jan; 40(1):35-40. PubMed ID: 11837381
    [Abstract] [Full Text] [Related]

  • 23. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
    Vaidyanathan S, Valencia J, Kemp C, Zhao C, Yeh CM, Bizot MN, Denouel J, Dieterich HA, Dole WP.
    Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
    [Abstract] [Full Text] [Related]

  • 24. High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method.
    Daneshtalab N, Lewanczuk RZ, Jamali F.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan 25; 766(2):345-9. PubMed ID: 11824822
    [Abstract] [Full Text] [Related]

  • 25. Rheumatoid arthritis does not reduce the pharmacodynamic response to valsartan.
    Daneshtalab N, Lewanczuk RZ, Russell A, Jamali F.
    J Clin Pharmacol; 2004 Mar 25; 44(3):245-52. PubMed ID: 14973301
    [Abstract] [Full Text] [Related]

  • 26. [Comparative efficacy of original and generic valsartan arterial hypertension].
    Nedogoda SV, Lediaeva AA, Mazina GG, Chumachek EV, Salasiuk AS, Tsoma VV.
    Kardiologiia; 2011 Mar 25; 51(9):22-8. PubMed ID: 22141186
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects.
    Sunkara G, Reynolds CV, Pommier F, Humbert H, Yeh C, Prasad P.
    Curr Med Res Opin; 2007 Mar 25; 23(3):631-40. PubMed ID: 17355744
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Improved pH-independent dissolution and oral absorption of valsartan via the preparation of solid dispersion.
    Park YJ, Lee HK, Im YB, Lee W, Han HK.
    Arch Pharm Res; 2010 Aug 25; 33(8):1235-40. PubMed ID: 20803127
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of single and multiple oral doses of valsartan/amlodipine (80/5 mg) in healthy Chinese subjects.
    Duan J, Chen J, Yin Q, Karan R, Meiser K, Smith HT, Sunkara G.
    Int J Clin Pharmacol Ther; 2012 Jan 25; 50(1):33-43. PubMed ID: 22192643
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients.
    Miura M, Satoh S, Kagaya H, Saito M, Inoue T, Ohkubo T, Habuchi T, Suzuki T.
    J Clin Pharm Ther; 2009 Dec 25; 34(6):683-92. PubMed ID: 20175802
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension.
    Bhad P, Ayalasomayajula S, Karan R, Leon S, Riviere GJ, Sunkara G, Jarugula V.
    J Clin Pharmacol; 2011 Jun 25; 51(6):933-42. PubMed ID: 20852001
    [Abstract] [Full Text] [Related]

  • 35. Simultaneous determination of fixed dose combination of nebivolol and valsartan in human plasma by liquid chromatographic-tandem mass spectrometry and its application to pharmacokinetic study.
    Selvan PS, Gowda KV, Mandal U, Solomon WD, Pal TK.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct 15; 858(1-2):143-50. PubMed ID: 17884739
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of age and gender on the pharmacokinetics of eprosartan.
    Tenero DM, Martin DE, Miller AK, Ilson B, Boike SC, Zariffa N, Jorkasky DK.
    Br J Clin Pharmacol; 1998 Sep 15; 46(3):267-70. PubMed ID: 9764969
    [Abstract] [Full Text] [Related]

  • 38. The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects.
    Morgan JM, Palmisano M, Piraino A, Hirschhorn W, Spencer S, Prasad PP, Ortiz M, Lloyd P.
    Clin Pharmacol Ther; 1997 Jan 15; 61(1):35-44. PubMed ID: 9024172
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.